Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants

Transplant Proc. 1998 Aug;30(5):1685-7. doi: 10.1016/s0041-1345(98)00393-5.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Antifungal Agents / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Cyclosporine / administration & dosage
  • Cyclosporine / blood
  • Cyclosporine / pharmacokinetics*
  • Cyclosporine / therapeutic use*
  • Diltiazem / therapeutic use*
  • Drug Interactions
  • Drug Monitoring
  • Drug Therapy, Combination
  • Half-Life
  • Humans
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / pharmacokinetics*
  • Immunosuppressive Agents / therapeutic use*
  • Ketoconazole / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Regression Analysis

Substances

  • Antifungal Agents
  • Calcium Channel Blockers
  • Immunosuppressive Agents
  • Cyclosporine
  • Diltiazem
  • Ketoconazole